Literature DB >> 32016904

Silencing CCNG1 protects MPC-5 cells from high glucose-induced proliferation-inhibition and apoptosis-promotion via MDM2/p53 signaling pathway.

Ye Chen1, Rui Yan1, Bo Li1, Jun Liu1, Xiaoxia Liu1, Wenyu Song1, Chunling Zhu2.   

Abstract

PURPOSE: Diabetic nephropathy (DN) is one of the most serious complications of diabetes mellitus and one of the most important causes of end-stage renal disease, but its pathogenesis has not been elucidated so far, and there is no effective treatment.
METHODS: DN models of rats and MPC-5 cells were established with streptozotocin (STZ) and high glucose (HG) in vivo and in vitro, respectively. Cell markers desmin and nephrin in foot kidney tissue were detected by Western blot. CCNG1 level in vitro was analyzed by Western blot and immunohistochemistry. CCK-8 assay and flow cytometry were conducted to analyze the effect of CCNG1 on HG-treated MPC-5 cells. Apoptosis-related proteins (Bcl-2, Bax and p53), CCNG1, and MDM2 were determined by RT-qPCR and Western blot.
RESULTS: The level of nephrin was decreased, while desmin was increased in STZ-induced DN rats and CCNG1 level was also enhanced by STZ. In vitro experiments indicated that MPC-5 cell viability was inhibited and apoptosis was induced by HG and we also found that CCNG1 expression was up-regulated by HG and negatively correlated with MDM2 level. The effects of HG on MPC-5 cell viability, apoptosis, and cell cycle were reversed by silencing CCNG1, but further deteriorated by overexpression of CCNG1. Furthermore, overexpression of MDM2 inhibited HG-induced MPC-5 cell injury and CCNG1 expression.
CONCLUSIONS: These findings revealed that down-regulation of CCNG1 has protection effects in DN that is mechanistically linked to MDM2-p53 pathways.

Entities:  

Keywords:  CCNG1; Diabetic nephropathy; High glucose; MDM2; p53

Year:  2020        PMID: 32016904     DOI: 10.1007/s11255-020-02383-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  27 in total

1.  Mechanisms of p53 activation and physiological relevance in the developing kidney.

Authors:  Karam Aboudehen; Sylvia Hilliard; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-11

2.  Lysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2A.

Authors:  Hongyun Li; Koji Okamoto; Melissa J Peart; Carol Prives
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

3.  MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.

Authors:  Weiying Guo; Dan Tian; Ye Jia; Wenlin Huang; Mengnan Jiang; Junnan Wang; Weixia Sun; Hao Wu
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-04-26       Impact factor: 4.739

4.  Mdm2 is required for maintenance of the nephrogenic niche.

Authors:  Sylvia A Hilliard; Xiao Yao; Samir S El-Dahr
Journal:  Dev Biol       Date:  2014-01-17       Impact factor: 3.582

5.  Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line.

Authors:  L Cahilly-Snyder; T Yang-Feng; U Francke; D L George
Journal:  Somat Cell Mol Genet       Date:  1987-05

6.  The expression of cyclin G in nasopharyngeal carcinoma and its significance.

Authors:  Xing-Xing Ye; Chi-Bo Liu; Jia-Yu Chen; Bao-Hong Tao; Cai Zhi-Yi
Journal:  Clin Exp Med       Date:  2011-06-19       Impact factor: 3.984

7.  Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein.

Authors:  Shinya H Kimura; Hiroshi Nojima
Journal:  Genes Cells       Date:  2002-08       Impact factor: 1.891

8.  Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer.

Authors:  Hakan Korkmaz; Wei Du; George H Yoo; Ileana I Enamorado; Ho-Sheng Lin; Volkan Adsay; Danny Kewson; John F Ensley; Terry Y Shibuya; John R Jacobs; Harold Kim
Journal:  Am J Otolaryngol       Date:  2005 Mar-Apr       Impact factor: 1.808

9.  MDM2 regulates a novel form of incomplete neoplastic transformation of Theileria parva infected lymphocytes.

Authors:  Kyoko Hayashida; Kiichi Kajino; Masakazu Hattori; Maura Wallace; Ivan Morrison; Mark I Greene; Chihiro Sugimoto
Journal:  Exp Mol Pathol       Date:  2012-09-07       Impact factor: 3.362

10.  The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer.

Authors:  Yulong Shang; Bin Feng; Lin Zhou; Gui Ren; Zhiyong Zhang; Xing Fan; Yi Sun; Guanhong Luo; Jie Liang; Kaichun Wu; Yongzhan Nie; Daiming Fan
Journal:  Oncotarget       Date:  2016-01-05
View more
  4 in total

1.  Forsythoside A Alleviates High Glucose-Induced Oxidative Stress and Inflammation in Podocytes by Inactivating MAPK Signaling via MMP12 Inhibition.

Authors:  Xiaohong Quan; Huihui Liu; Dongmei Ye; Xinling Ding; Xiulan Su
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-28       Impact factor: 3.168

2.  lncRNA MSC-AS1 Aggravates Diabetic Nephropathy by Regulating the miR-325/CCNG1 Axis.

Authors:  Hongtu Zhao; Yuanyuan Cui; Fuqing Dong; Wencong Li
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

3.  Transcriptome Analysis Reveal Candidate Genes and Pathways Responses to Lactate Dehydrogenase Inhibition (Oxamate) in Hyperglycemic Human Renal Proximal Epithelial Tubular Cells.

Authors:  Zhimin Wang; Dan Hao; Dong Fang; Jiating Yu; Xiao Wang; Guijun Qin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-17       Impact factor: 5.555

4.  Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.

Authors:  Shaojie Fu; Yena Zhou; Cong Hu; Zhonggao Xu; Jie Hou
Journal:  BMC Complement Med Ther       Date:  2022-08-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.